Levetiracetam 500mg/5ml Intravenous (IV) Injection

Levetiracetam 500mg/5ml Intravenous (IV) Injection

Levetiracetam, available as a 500mg/5ml intravenous injection, is a cutting-edge antiepileptic medication designed for the management of seizures in adults and children. This formulation is specifically tailored for patients requiring rapid administration of levetiracetam, particularly in a hospital or emergency care setting.

Product Specifications:
- Concentration: 500mg of Levetiracetam per 5ml solution
- Administration: Intravenous use only
- Packaging: Sterile, single-use vials to ensure safety and efficacy
- Storage: Store between 15°C to 30°C (59°F to 86°F); protect from light
- Compatibility: Should not be mixed with other medications or solvents

Common Applications:
- Acute treatment of seizure clusters
- Adjunctive therapy for partial-onset seizures
- Replacement therapy for patients unable to take oral formulations
- Bridging therapy during perioperative periods

User Groups:
- Patients with epilepsy or seizure disorders
- Individuals with compromised gastrointestinal function
- Hospitalized patients requiring controlled dosage and rapid administration
- Patients with an established diagnosis requiring maintenance antiepileptic therapy

Overview of Pfizer:
Pfizer is a global leader in the pharmaceutical industry, renowned for its commitment to innovation, safety, and quality. With a legacy spanning over 170 years, Pfizer has established itself as an authority in the development and manufacturing of medications across a wide range of therapeutic areas, including neurology. Their dedication to advancing healthcare is reflected in their rigorous research and development processes, ensuring that products like Levetiracetam IV injections meet the highest standards of efficacy and patient safety. As a trusted name in the medical community, Pfizer continues to be at the forefront of providing life-changing treatments to patients worldwide.